215 related articles for article (PubMed ID: 28317530)
1. Depigmentation Therapies for Vitiligo.
Grimes PE; Nashawati R
Dermatol Clin; 2017 Apr; 35(2):219-227. PubMed ID: 28317530
[TBL] [Abstract][Full Text] [Related]
2. Depigmentation therapies in vitiligo.
Gupta D; Kumari R; Thappa DM
Indian J Dermatol Venereol Leprol; 2012; 78(1):49-58. PubMed ID: 22199060
[TBL] [Abstract][Full Text] [Related]
3. Depigmentation therapies for normal skin in vitiligo universalis.
AlGhamdi KM; Kumar A
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
Webb KC; Eby JM; Hariharan V; Hernandez C; Luiten RM; Le Poole IC
Exp Dermatol; 2014 Aug; 23(8):529-33. PubMed ID: 24840876
[TBL] [Abstract][Full Text] [Related]
5. Advanced treatment modalities for vitiligo.
Patel NS; Paghdal KV; Cohen GF
Dermatol Surg; 2012 Mar; 38(3):381-91. PubMed ID: 22288899
[TBL] [Abstract][Full Text] [Related]
6. Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
Oakley AM
Australas J Dermatol; 1996 May; 37(2):96-8. PubMed ID: 8687336
[TBL] [Abstract][Full Text] [Related]
7. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser.
Njoo MD; Vodegel RM; Westerhof W
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):760-9. PubMed ID: 10775851
[TBL] [Abstract][Full Text] [Related]
8. Laser (755 nm) and cryotherapy as depigmentation treatments for vitiligo: a comparative study.
van Geel N; Depaepe L; Speeckaert R
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1121-7. PubMed ID: 25286980
[TBL] [Abstract][Full Text] [Related]
9. Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole.
Di Nuzzo S; Masotti A
Clin Exp Dermatol; 2010 Mar; 35(2):215-6. PubMed ID: 20447090
[TBL] [Abstract][Full Text] [Related]
10. Accelerating bleaching in vitiligo: balancing benefits versus risks.
Seneschal J; Boniface K; Ezzedine K; Taieb A
Exp Dermatol; 2014 Dec; 23(12):879-80. PubMed ID: 25039467
[TBL] [Abstract][Full Text] [Related]
11. What's New in Pigmentary Disorders.
Zubair R; Lyons AB; Vellaichamy G; Peacock A; Hamzavi I
Dermatol Clin; 2019 Apr; 37(2):175-181. PubMed ID: 30850040
[TBL] [Abstract][Full Text] [Related]
12. Site-oriented depigmentation in vitiligo patients using Q-switched Nd:YAG laser (1,064/532 nm), cryotherapy and chemical peels: A comparative study.
El-Mofty M; Mostafa WZ; Esmat S; Zayed A; Mashaly H; Hussien MF; Ismail SI
Dermatol Ther; 2019 Sep; 32(5):e13052. PubMed ID: 31376312
[TBL] [Abstract][Full Text] [Related]
13. Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
Hariharan V; Klarquist J; Reust MJ; Koshoffer A; McKee MD; Boissy RE; Le Poole IC
J Invest Dermatol; 2010 Jan; 130(1):211-20. PubMed ID: 19657355
[TBL] [Abstract][Full Text] [Related]
14. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.
Mosher DB; Parrish JA; Fitzpatrick TB
Br J Dermatol; 1977 Dec; 97(6):669-79. PubMed ID: 603749
[TBL] [Abstract][Full Text] [Related]
15. Depigmentation of the normally pigmented patches in universal vitiligo patients by cryotherapy.
Radmanesh M
J Eur Acad Dermatol Venereol; 2000 May; 14(3):149-52. PubMed ID: 11032055
[TBL] [Abstract][Full Text] [Related]
16. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes.
Hossani-Madani A; Halder R
G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273
[TBL] [Abstract][Full Text] [Related]
17. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).
McGuinn KP; Saedi N; Green JB; Dover JS
Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165
[No Abstract] [Full Text] [Related]
18. Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening.
Grau C; Silverberg NB
Cutis; 2013 May; 91(5):248-52. PubMed ID: 23772431
[TBL] [Abstract][Full Text] [Related]
19. Effects of Monobenzyl ether of hydroquinone on 3T3 mouse fibroblast viability and ultrastructure.
Erdoğan A; Mutlu HS; Doğan S; Kotil T
Ultrastruct Pathol; 2021 Nov; 45(6):384-390. PubMed ID: 34875974
[TBL] [Abstract][Full Text] [Related]
20. Vitiligo. Therapeutic advances.
Jimbow K
Dermatol Clin; 1998 Apr; 16(2):399-407. PubMed ID: 9589212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
